Please login to the form below

Not currently logged in

Merck appoints head of combined life science business

Udit Batra is CEO and president of Merck Millipore

Merck Udit BatraMerck has named Udit Batra to lead the combined life science business of Merck Millipore and Sigma-Alrich.

The appointment will be effective upon successful completion of the acquisition, expected for mid-2015.

Batra joined Merck in 2011 to head the group's consumer health business. Prior to that, he worked at Novartis Vaccines nd Diagnostics, where he served as head of global public health and market access.

Batra has been CEO and president of Merck Millipore since March 2014 and will, alongside Sigma-Aldrich president and CEO Rakesh Sachdev, will continue to run both organisations independently leading up to the acquisition.

Karl-Ludwig Kley, chairman of the executive board of Merck, commented: “Today's appointment marks another important step in the acquisition of Sigma-Aldrich as it provides stable and strong leadership and continued customer focus during the crucial months of integration planning and beyond.

“Udit is a proven leader who has demonstrated his ability to work successfully with his leadership team to guide large organisations, drive performance and deliver to our customers.”

15th April 2015

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Haseeb Ahmad
Can value-based healthcare take off and reach for the skies?
Are companies willing to contribute to the change in the healthcare system?...
Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...